192 related articles for article (PubMed ID: 35320731)
1. Therapeutic modulation of GSTO activity rescues FUS-associated neurotoxicity via deglutathionylation in ALS disease models.
Cha SJ; Lee S; Choi HJ; Han YJ; Jeon YM; Jo M; Lee S; Nahm M; Lim SM; Kim SH; Kim HJ; Kim K
Dev Cell; 2022 Mar; 57(6):783-798.e8. PubMed ID: 35320731
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of glutathione S-transferase leads to mislocalization and accumulation of cabeza, a
Cha SJ; Yoon JH; Han YJ; Kim K
J Neurogenet; 2023; 37(1-2):20-24. PubMed ID: 36437507
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
4. FUS-induced neurotoxicity is prevented by inhibiting GSK-3β in a Drosophila model of amyotrophic lateral sclerosis.
Choi HJ; Lee JY; Cha SJ; Han YJ; Yoon JH; Kim HJ; Kim K
Hum Mol Genet; 2022 Mar; 31(6):850-862. PubMed ID: 34605896
[TBL] [Abstract][Full Text] [Related]
5. Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition.
Pelaez MC; Desmeules A; Gelon PA; Glasson B; Marcadet L; Rodgers A; Phaneuf D; Pozzi S; Dutchak PA; Julien JP; Sephton CF
Acta Neuropathol Commun; 2023 Nov; 11(1):182. PubMed ID: 37974279
[TBL] [Abstract][Full Text] [Related]
6. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A Relieves Growth Suppression and Restores Histone Acetylation at Specific Sites in a FUS ALS/FTD Yeast Model.
Bennett SA; Cobos SN; Mirzakandova M; Fallah M; Son E; Angelakakis G; Rana N; Hugais M; Torrente MP
Biochemistry; 2021 Dec; 60(48):3671-3675. PubMed ID: 34788013
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R; Neumann M
Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
[TBL] [Abstract][Full Text] [Related]
9. Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis.
Cha SJ; Choi HJ; Kim HJ; Choi EJ; Song KH; Im DS; Kim K
Insect Mol Biol; 2020 Feb; 29(1):56-65. PubMed ID: 31290213
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
Shang Y; Huang EJ
Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
[TBL] [Abstract][Full Text] [Related]
11. Dendritic Homeostasis Disruption in a Novel Frontotemporal Dementia Mouse Model Expressing Cytoplasmic Fused in Sarcoma.
Shiihashi G; Ito D; Arai I; Kobayashi Y; Hayashi K; Otsuka S; Nakajima K; Yuzaki M; Itohara S; Suzuki N
EBioMedicine; 2017 Oct; 24():102-115. PubMed ID: 28928015
[TBL] [Abstract][Full Text] [Related]
12. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
Nolan M; Talbot K; Ansorge O
Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
[TBL] [Abstract][Full Text] [Related]
14. DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.
Fortuna TR; Kour S; Anderson EN; Ward C; Rajasundaram D; Donnelly CJ; Hermann A; Wyne H; Shewmaker F; Pandey UB
Acta Neuropathol; 2021 Sep; 142(3):515-536. PubMed ID: 34061233
[TBL] [Abstract][Full Text] [Related]
15. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration.
Kishino Y; Matsukawa K; Matsumoto T; Miyazaki R; Wakabayashi T; Nonaka T; Kametani F; Hasegawa M; Hashimoto T; Iwatsubo T
J Biol Chem; 2022 Aug; 298(8):102191. PubMed ID: 35753345
[TBL] [Abstract][Full Text] [Related]
16. FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins.
Steyaert J; Scheveneels W; Vanneste J; Van Damme P; Robberecht W; Callaerts P; Bogaert E; Van Den Bosch L
Hum Mol Genet; 2018 Dec; 27(23):4103-4116. PubMed ID: 30379317
[TBL] [Abstract][Full Text] [Related]
17. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
Wang T; Jiang X; Chen G; Xu J
Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
[TBL] [Abstract][Full Text] [Related]
18. Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma.
Ito D; Taguchi R; Deguchi M; Ogasawara H; Inoue E
Sci Rep; 2020 Mar; 10(1):4857. PubMed ID: 32184412
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Hippo and cJun-N-terminal Kinase (JNK) signaling mitigate FUS mediated neurodegeneration in vivo.
Gogia N; Sarkar A; Mehta AS; Ramesh N; Deshpande P; Kango-Singh M; Pandey UB; Singh A
Neurobiol Dis; 2020 Jul; 140():104837. PubMed ID: 32199908
[TBL] [Abstract][Full Text] [Related]
20. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
